|
|
Volumn 45, Issue 9, 2006, Pages 1100-
|
|
Clinical vignette
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADALIMUMAB;
ANTIBIOTIC AGENT;
AZATHIOPRINE;
C REACTIVE PROTEIN;
CORTICOSTEROID;
CYCLOPHOSPHAMIDE;
DISEASE MODIFYING ANTIRHEUMATIC DRUG;
INFLIXIMAB;
METHOTREXATE;
PROSTAGLANDIN;
SALAZOSULFAPYRIDINE;
TUMOR NECROSIS FACTOR ANTIBODY;
ANTIRHEUMATIC AGENT;
MONOCLONAL ANTIBODY;
RHEUMATOID FACTOR;
TUMOR NECROSIS FACTOR ALPHA;
AGED;
ARTICLE;
CASE REPORT;
CLINICAL PROTOCOL;
DISEASE MARKER;
DRUG EFFICACY;
DRUG TREATMENT FAILURE;
ERYTHROCYTE SEDIMENTATION RATE;
FELTY SYNDROME;
HUMAN;
MAINTENANCE THERAPY;
MALE;
NEUTROPENIA;
OSTEOPOROSIS;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
SEPSIS;
SKIN ULCER;
SPLENOMEGALY;
VASCULITIS;
ANKLE;
BLOOD;
DRUG ANTAGONISM;
FOOT ULCER;
MIDDLE AGED;
ANKLE JOINT;
ANTIBODIES, MONOCLONAL;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
FOOT ULCER;
HUMANS;
MALE;
MIDDLE AGED;
RHEUMATOID FACTOR;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 33749645852
PISSN: 14620324
EISSN: 14620332
Source Type: Journal
DOI: 10.1093/rheumatology/kel055 Document Type: Article |
|
Times cited : (2)
|
|
References (2)
|
